News · 26 weeks58+25%
2025-12-282026-06-21
Mix2790d
- Other10(37%)
- Insider10(37%)
- Earnings2(7%)
- Leadership2(7%)
- SEC Filings2(7%)
- Analyst1(4%)
Latest news
25 items- PRGridline Announces Strategic Integration With Hamilton Lane, Expanding Private Markets Benchmarking CapabilitiesPartnership enhances AI-powered AltComply with high-quality private markets benchmarking for wealth managers and investment teams Gridline, the turnkey platform wealth management firms rely on to manage the private markets lifecycle, today announced a strategic partnership and technology integration with Hamilton Lane (NASDAQ:HLNE), a leading global private markets investment firm. Drawing on Hamilton Lane’s extensive proprietary private markets data, Gridline has enhanced its AI-powered diligence solution, AltComply, with a new benchmarking engine. Hamilton Lane’s dataset offers one of the most comprehensive and timely views of the private markets. Launched in March 2026, AltComply h
- INSIDERExecutive Co-Chairman Rogers Hartley R. bought $3,005,339 worth of shares (38,290 units at $78.49), increasing direct ownership by 69% to 93,756 units (SEC Form 4)4 - Hamilton Lane INC (0001433642) (Issuer)
- INSIDERChief Operating Officer Kramer Andrea Anigati bought $99,381 worth of shares (1,283 units at $77.46), increasing direct ownership by 1% to 87,350 units (SEC Form 4)4 - Hamilton Lane INC (0001433642) (Issuer)
- INSIDERDirector Berkman David J bought $1,144,050 worth of shares (15,000 units at $76.27) (SEC Form 4)4 - Hamilton Lane INC (0001433642) (Issuer)
- INSIDERChief Operating Officer Kramer Andrea Anigati was granted 3,605 shares, increasing direct ownership by 4% to 86,067 units (SEC Form 4)4 - Hamilton Lane INC (0001433642) (Issuer)
- INSIDERChief Accounting Officer Carl Drew Thomas was granted 675 shares, increasing direct ownership by 58% to 1,846 units (SEC Form 4)4 - Hamilton Lane INC (0001433642) (Issuer)
- INSIDERChief Financial Officer Armbrister Jeffrey Brian was granted 2,109 shares, increasing direct ownership by 19% to 12,958 units (SEC Form 4)4 - Hamilton Lane INC (0001433642) (Issuer)
- INSIDERGeneral Counsel & Secretary Gavalis Lydia was granted 1,139 shares, increasing direct ownership by 3% to 34,028 units (SEC Form 4)4 - Hamilton Lane INC (0001433642) (Issuer)
- INSIDERCo-Chief Executive Officer Delgado-Moreira Juan was granted 38,087 shares, increasing direct ownership by 3% to 1,376,134 units (SEC Form 4)4 - Hamilton Lane INC (0001433642) (Issuer)
- INSIDERCo-Chief Executive Officer Hirsch Erik R. was granted 42,145 shares, increasing direct ownership by 66% to 105,727 units (SEC Form 4)4 - Hamilton Lane INC (0001433642) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Hamilton Lane IncorporatedSCHEDULE 13D/A - Hamilton Lane INC (0001433642) (Subject)
- INSIDERExecutive Co-Chairman Rogers Hartley R. bought $9,992,338 worth of shares (110,932 units at $90.08) (SEC Form 4)4 - Hamilton Lane INC (0001433642) (Issuer)
- SECSEC Form 10-K filed by Hamilton Lane Incorporated10-K - Hamilton Lane INC (0001433642) (Filer)
- SECHamilton Lane Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Hamilton Lane INC (0001433642) (Filer)
- PRHAMILTON LANE INCORPORATED REPORTS FOURTH QUARTER AND FISCAL YEAR 2026 RESULTSCONSHOHOCKEN, Pa., May 21, 2026 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the fourth quarter and full fiscal year ended March 31, 2026. The Company issued a full detailed presentation of its fourth quarter and full fiscal year 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/.DividendHamilton Lane has declared a quarterly dividend of $0.60 per share of Class A common stock to record holders at the close of business on June 18, 2026 that will be paid on July 7, 2026. The target full-year dividend of $2.40 represents a 11% increase from t
- PRCosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)— Proven biopharmaceutical executive to lead commercial strategy as Cosette scales its branded pharmaceutical platform and advances its next phase of growth — Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today it has appointed David Bell as Chief Commercial Officer (Brands). David joins the company's executive leadership team as it continues to advance its ambitions in specialty pharmaceuticals and expand its commercial platform and portfolio. In this new role, David will oversee all branded commercial functions – including sales, marketing, market access, commercial operations, analytics, and portfolio strategy. He will be responsible
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Hamilton Lane IncorporatedSCHEDULE 13G/A - Hamilton Lane INC (0001433642) (Subject)
- PRMidOcean Announces Successful Close of Single-Asset Continuation Vehicle for CloyesMidOcean Partners ("MidOcean"), a premier New York-based alternative asset manager specializing in middle-market private equity, alternative credit, and structured equity, today announced the closing of a single-asset continuation vehicle for Cloyes Gear and Products, Inc. ("Cloyes" or the "Company"), the North American leader and global designer, developer, manufacturer, and distributor of mission-critical timing drive systems and components for the automotive aftermarket. The continuation vehicle secured approximately $300 million in commitments, with funds managed by Hamilton Lane (NASDAQ:HLNE) serving as sole lead investor. In connection with the continuation vehicle, MidOcean-managed
- PRCosette Pharmaceuticals Appoints Erika Tooman as Senior Vice President, General Counsel, Strengthening Leadership Team to Drive Accelerated Growth and Strategic Expansion-- Experienced life sciences executive to lead legal, compliance, and governance as Cosette scales its platform following recent acquisitions and continued growth momentum -- Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today that it has appointed Erika Tooman as Senior Vice President and General Counsel, strengthening the company's executive leadership team as it advances its long‑term growth, portfolio expansion, and value‑creation strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429022652/en/ Erika brings more than two decades of experience guiding pharmaceutica
- PRPower Sustainable Completes Sale of Minority Stake in Big Sky Wind to Institutional PartnersMONTREAL, April 29, 2026 /CNW/ - Power Sustainable Energy Infrastructure ("PSEI"), the renewable energy infrastructure platform of Power Sustainable, today announced it completed the sale of a 49.9% interest in Big Sky Wind, a 240 MW operating wind facility located in Illinois, to funds managed by Hamilton Lane (NASDAQ:HLNE) and GCM Grosvenor, two leading global private markets investment firms. PSEI will retain a majority interest in the asset and continue to oversee its operations. The transaction reflects PSEI's strategy of partnering with long-term institutional investors while actively recycling capital to fund new investments across its portfolio."We are pleased to partner with Hamilto
- PRHamilton Lane Incorporated to Announce Fourth Fiscal Quarter and Full Fiscal Year 2026 Results on May 21, 2026CONSHOHOCKEN, Pa., April 23, 2026 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2026 before the market opens on Thursday, May 21, 2026. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on May 21 to discuss the results for the fourth fiscal quarter and full fiscal year. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here at least 15 minutes prior to the start of the call. This f
- PRHamilton Lane Launches Two Interval Funds Across Private Credit and Private Infrastructure, Leveraging Extensive Expertise and Deep Track RecordsThe Hamilton Lane Credit Income Fund is now available to institutional and private wealth investors via the interval fund structureThe firm's Private Infrastructure Fund is now offered in an interval fund structure and is also available in a tokenized format through Republic's digital platformCONSHOHOCKEN, Pa., April 22, 2026 /PRNewswire/ -- Hamilton Lane (NASDAQ:HLNE) today announced the launch of the Hamilton Lane Credit Income Fund ("HLCIF") and the conversion of the Hamilton Lane Private Infrastructure Fund ("HLPIF") to an interval fund structure. Structured as interval funds, HLCIF and HLPIF are designed to offer institutional and private wealth investors in the U.S. access to private m
- PRHamilton Lane Announces Senior Promotions and AppointmentsOver 25 promotions and appointments to Managing Director and Principal reflect the firm's continued growth and expansion of its product offerings and client and investment teamsCONSHOHOCKEN, Pa., April 20, 2026 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (NASDAQ:HLNE) today announced senior promotions and new appointments across its Investment, Client Solutions, Portfolio Management, Legal, Finance and Operations Teams. The firm recognized the promotions of the following individuals to Managing Director:Anastasia Di Carlo, Client SolutionsBrian Reilly, Taft-HartleyEmily Lozada, Investment LegalJan Verstraete, Secondary InvestmentsKaylin Liu, Fund Ac
- ANALYSTHamilton Lane upgraded by Analyst with a new price targetAnalyst upgraded Hamilton Lane from Neutral to Overweight and set a new price target of $166.00
- PRCosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio-- Adds Portfolio of Branded Products with $48.9 million in 2025 Net Sales and an Established Commercial Presence -- -- SYMPAZAN® Establishes a Neurology Rare Disease Footprint within Cosette -- -- Additional Brands include INDOCIN®, SPRIX®, ZIPSOR®, CAMBIA®, and OTREXUP® -- Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today the closing of a definitive agreement to acquire the U.S. sales and distribution rights for a portfolio of seven branded products from Assertio Holdings, Inc. (NASDAQ:ASRT). The acquisition expands Cosette's branded portfolio and adds the U.S. rights to SYMPAZAN®, a growing, patent-protected asset, further advanc
HLNE FAQ
7 questionsWhat does Hamilton Lane Incorporated do?
Hamilton Lane Incorporated is an investment firm specializing in direct and fund of fund investments. It provides following services: separate accounts (customized to each individual client and structured as single client vehicles); specialized strategies (fund-of-funds, secondaries, co-investments, taft-hartley, distribution management); advisory relationships (including due diligence, strategic portfolio planning, monitoring and reporting services); and reporting and analytics solutions. For direct investments, the firm invests in early, mid and late venture, mature companies, growth...Where does HLNE stock trade?
Hamilton Lane Incorporated (HLNE) is listed on NASDAQ.What sector and industry is HLNE in?
Hamilton Lane Incorporated operates in the Finance sector, Investment Managers industry.When did Hamilton Lane Incorporated go public?
Hamilton Lane Incorporated (HLNE) completed its IPO in 2017.What are analysts saying about HLNE?
Hamilton Lane Incorporated has had 8 recent analyst actions on file. The most recent action was from Analyst: Overweight on 2026-04-16.What companies are similar to HLNE?
Notable peers in the same industry include BX (Blackstone Inc.), KKR (KKR & Co. Inc.), APO (Apollo Global Management Inc. (New)), AMP (Ameriprise Financial Inc.), ARES (Ares Management Corporation). Compare HLNE side-by-side with any of them on Quantisnow.How can I track HLNE on Quantisnow?
Quantisnow aggregates Hamilton Lane Incorporated's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HLNE to receive live email and push alerts on every new disclosure.